Evonik rejects $11.7 billion BASF takeover bid, sources say

By Reuters News

Sept 28 (Reuters) - German chemicals manufacturer Evonik EVKn.DE has rejected a €10.3 billion ($11.70 billion) takeover bid from larger rival and BASF BASFn.DE for being too low, sources close to the negotiations told Reuters on Monday.

BASF, one of the world's largest chemicals makers, had offered about €22.15 per Evonik share, the sources said.

BASF had said late last week that it was in "exploratory" talks with Evonik and on Monday said it would not comment on price. Evonik declined to comment.

Evonik's products include high-tech plastics and feed additives as well as ingredients for coatings and household products. BASF makes engineering plastics, super absorbent polymers, vitamins and a wide range of chemicals for industrial uses.

BASF is at risk of losing its ranking as the world's largest company by chemicals revenue to China's Sinopec 600028.SS.

Last year BASF's group revenue of €59.7 billion was almost the same as that of Sinopec's chemicals division.

($1 = 0.8800 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.